221 related articles for article (PubMed ID: 24630634)
1. [Peritoneal malignant mesothelioma: review and recent data].
Mery É; Hommell-Fontaine J; Capovilla M; Chevallier A; Bibeau F; Croce S; Dartigues P; Kaci R; Lang-Averous G; Laverriere MH; Leroux-Broussier A; Poizat F; Robin N; Valmary-Degano S; Verriele-Beurrier V; Villeneuve L; Isaac S
Ann Pathol; 2014 Feb; 34(1):26-33. PubMed ID: 24630634
[TBL] [Abstract][Full Text] [Related]
2. Pathohistological diagnosis and differential diagnosis.
Tischoff I; Neid M; Neumann V; Tannapfel A
Recent Results Cancer Res; 2011; 189():57-78. PubMed ID: 21479896
[TBL] [Abstract][Full Text] [Related]
3. Multicystic and diffuse malignant peritoneal mesothelioma in children.
Vermersch S; Arnaud A; Orbach D; Andre N; Berger C; Kepenekian V; Brigand C; Fresneau B; Poli-Merol ML; Habougit C; Varlet F; Scalabre A
Pediatr Blood Cancer; 2020 Jun; 67(6):e28286. PubMed ID: 32277799
[TBL] [Abstract][Full Text] [Related]
4. Diffuse malignant biphasic peritoneal mesothelioma with cystic areas.
Cabibi D; Tutino R; Salamone G; Cocorullo G; Agrusa A; Gulotta G
Ann Ital Chir; 2016 Jun; 87():. PubMed ID: 27320084
[TBL] [Abstract][Full Text] [Related]
5. Diffuse malignant peritoneal mesothelioma.
Shih CA; Ho SP; Tsay FW; Lai KH; Hsu PI
Kaohsiung J Med Sci; 2013 Nov; 29(11):642-5. PubMed ID: 24183360
[TBL] [Abstract][Full Text] [Related]
6. Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases.
Pavlisko EN; Roggli VL
Am J Surg Pathol; 2015 Nov; 39(11):1568-75. PubMed ID: 26371785
[TBL] [Abstract][Full Text] [Related]
7. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.
Dragon J; Thompson J; MacPherson M; Shukla A
J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.
Xing D; Banet N; Sharma R; Vang R; Ronnett BM; Illei PB
Hum Pathol; 2018 Feb; 72():160-166. PubMed ID: 29241740
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F
Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912
[TBL] [Abstract][Full Text] [Related]
10. Malignant peritoneal mesothelioma in patients with endometriosis.
Butnor KJ; Rueckert J; Pavlisko EN; Sporn TA; Roggli VL
J Clin Pathol; 2018 Nov; 71(11):971-974. PubMed ID: 29794065
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial.
de Boer NL; van Kooten JP; Burger JWA; Verhoef C; Aerts JGJV; Madsen EVE
BMJ Open; 2019 May; 9(5):e026779. PubMed ID: 31092657
[TBL] [Abstract][Full Text] [Related]
12. The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
Marchevsky AM; LeStang N; Hiroshima K; Pelosi G; Attanoos R; Churg A; Chirieac L; Dacic S; Husain A; Khoor A; Klebe S; Lantuejoul S; Roggli V; Vignaud JM; Weynard B; Sauter J; Henderson D; Nabeshima K; Galateau-Salle F
Hum Pathol; 2017 Sep; 67():160-168. PubMed ID: 28782639
[TBL] [Abstract][Full Text] [Related]
13. Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features.
Marqués M; Tranchant R; Risa-Ebrí B; Suárez-Solís ML; Fernández LC; Carrillo-de-Santa-Pau E; Del Pozo N; Martínez de Villarreal J; Meiller C; Allory Y; Blum Y; Pirker C; Hegedus B; Barry ST; Carnero A; Berger W; Jean D; Real FX
Cancer Res; 2020 Feb; 80(4):843-856. PubMed ID: 31911549
[TBL] [Abstract][Full Text] [Related]
14. Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases.
Pavlisko EN; Liu B; Green C; Sporn TA; Roggli VL
Am J Surg Pathol; 2020 Mar; 44(3):293-304. PubMed ID: 31876584
[TBL] [Abstract][Full Text] [Related]
15. Primary Malignant Deciduoid Mesothelioma: A Challenging Diagnosis.
Regragui M; Guebessi NB
Arch Pathol Lab Med; 2019 Apr; 143(4):531-533. PubMed ID: 30500290
[TBL] [Abstract][Full Text] [Related]
16. Localized multiple malignant epithelioid peritoneal mesotheliomas arising from the hepatoduodenal ligament and diaphragm: a case report.
Miyata T; Fujiwara Y; Nishijima K; Futagami F; Nakamura T; Takamura H
J Med Case Rep; 2019 Mar; 13(1):66. PubMed ID: 30879467
[TBL] [Abstract][Full Text] [Related]
17. Myxoid variant of peritoneal epithelioid malignant mesothelioma. A case report.
Goldová B; Dundr P; Zikán M; Tomancová V
Cesk Patol; 2014 Jul; 50(3):149-51. PubMed ID: 25186596
[TBL] [Abstract][Full Text] [Related]
18. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
Lee M; Alexander HR; Burke A
Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
[TBL] [Abstract][Full Text] [Related]
19. Malignant peritoneal mesothelioma and Crohn disease.
Butnor KJ; Pavlisko EN; Sporn TA; Roggli VL
J Clin Pathol; 2017 Mar; 70(3):228-232. PubMed ID: 27484913
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]